Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Neurology

Genetics and Diagnostic Testing for FTLE

At a Glance

Familial temporal lobe epilepsy is diagnosed using the seizure story, a three-generation family history, video-EEG, MRI, and sometimes genetic testing. A normal MRI or negative genetic result does not rule it out, and a genetic counselor can explain family risks.

Diagnosing familial temporal lobe epilepsy (FTLE) is like solving a puzzle where the pieces come from your symptoms, your brain’s electrical activity, and your family tree [1]. Because your brain structure may look perfectly healthy on standard scans, the diagnosis relies heavily on the “story” of your family history [2].

The Genetic Landscape

It is helpful to think of FTLE genetics in two ways: monogenic (caused by a single gene variant) and polygenic (caused by many genetic variations) [1].

Monogenic Causes (The Single Switch)

In some families, a single “glitch” in one gene drives the seizures. If a parent has a confirmed heterozygous pathogenic autosomal dominant variant, there is a 50% chance of passing that gene to each child [3]. Key genes include:

  • LGI1 and RELN: These genes are found in some families who experience auditory symptoms (hearing sounds or voices) [4][5].
  • DEPDC5, NPRL2, and NPRL3: These belong to the GATOR1 complex, which helps regulate cell growth in the brain. Variants here are broader familial focal epilepsy genes that can cause a variety of focal seizures [6][7].

Polygenic Causes (The Complex Map)

For many other families, especially those with mesial symptoms (like déjà vu), there isn’t one single known “seizure gene.” Instead, they may have inherited a collection of many small genetic traits (polygenic risk) [1]. Note that polygenic risk scores are currently a research concept and not established as routine clinical tests for diagnosing patients.

The Concept of Incomplete Penetrance

One of the most confusing parts of genetic epilepsy is incomplete penetrance. This means that even if you inherit a pathogenic gene variant, you might never actually have a seizure [8].

In some FTLE families, penetrance is variable [8][9]. Because of this, absence of seizures does not rule out carrier status—your parent might carry the gene but simply never had a seizure [10].

Standard Diagnostic Tools

To confirm a diagnosis of FTLE, your care team will use several tools:

  1. 3-Generation Family History: This is a crucial tool. Your doctor will ask about parents, siblings, children, aunts, uncles, and grandparents to look for a pattern of seizures or “spells” [1].
  2. High-Resolution MRI: Doctors use a specific “epilepsy protocol” MRI to look for tiny changes, such as hippocampal sclerosis (scarring in the memory center) [1]. However, in many types of FTLE, the MRI is completely normal because the issue is in electrical communication, not visible structure [1][11].
  3. Video-EEG: This test records your brain’s electrical activity and your physical movements at the same time. It is a central tool for seeing where a seizure starts [12]. However, a routine scalp EEG or even video-EEG can sometimes miss deep mesial temporal seizures unless a typical event is captured, or invasive monitoring is used.
  4. Neuropsychological Testing: These are memory and language “puzzles.” Normal memory scores do not rule out epilepsy [11].

The Role of Genetic Testing

Genetic testing is increasingly recommended for people with focal epilepsy and a family history [13].

  • Why Test? Finding a specific gene can sometimes help confirm the diagnosis and inform family risk assessment. While it occasionally influences medication choices, genetic testing in FTLE is usually more useful for counseling than for picking a specific drug [14].
  • Genetic Counseling: Before testing, it is vital to speak with a genetic counselor. They can explain what results might mean for you and your relatives [15][13].
  • Variants of Uncertain Significance (VUS): Testing may reveal a VUS. A VUS should not be used to guide treatment or predictive testing for relatives.
  • A “Negative” Result: A negative genetic test simply means a known mutation wasn’t found; it does not rule out familial epilepsy [1]. The diagnosis is based on your full clinical picture.

Common questions in this guide

How is familial temporal lobe epilepsy diagnosed if an MRI is normal?
Diagnosis combines the seizure description, a three-generation family history, an epilepsy-protocol MRI, video-EEG, and sometimes neuropsychological testing. Many people with familial temporal lobe epilepsy have normal brain scans or memory scores, so normal results do not rule out epilepsy. Routine EEG or video-EEG can also miss seizures that begin deep in the temporal lobe unless a typical event is recorded.
Which genes might be included in testing for familial temporal lobe epilepsy?
Depending on the seizure pattern and family history, a testing panel may include LGI1 and RELN, as well as DEPDC5, NPRL2, and NPRL3, which are part of the GATOR1 complex. These genes are linked to some familial epilepsy patterns, but not every person with familial temporal lobe epilepsy has a change in one of them. A genetic counselor can help select and interpret the appropriate test.
What does a negative genetic test mean in familial temporal lobe epilepsy?
A negative result means that the test did not find a known genetic change included in the analysis. It does not rule out familial epilepsy because the cause may involve genes that are not yet known, many small genetic factors, or a change the test cannot detect. Diagnosis still depends on the full clinical and family history.
What does incomplete penetrance mean for an epilepsy gene?
Incomplete penetrance means that a person can inherit a disease-causing gene change but never have a seizure. As a result, a parent or relative without seizures may still carry the familial variant. This is why family counseling and testing decisions should not rely only on whether someone has had seizures.
Should a variant of uncertain significance change epilepsy treatment?
No. A variant of uncertain significance is a genetic finding whose health meaning is not clear, so it should not be used to guide treatment or predictive testing for relatives. Your treating clinician and genetic counselor can explain what the result does and does not show.
What could a confirmed epilepsy gene variant mean for my children?
If a parent has a confirmed pathogenic variant inherited in an autosomal dominant pattern, each child has a 50% chance of inheriting it. Inheriting the variant does not guarantee seizures because penetrance can be incomplete. A genetic counselor can discuss testing and family planning in the context of the specific variant.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can we map out a three-generation family tree together to better understand the patterns in my family?
  2. 2.Which specific genetic testing panel is most appropriate for my symptoms, and does it include the LGI1, RELN, and GATOR1 genes?
  3. 3.If my MRI and memory tests are normal, what does that tell us about the likely cause or 'neighborhood' of my seizures?
  4. 4.Should we consider a Video-EEG to capture an event, and how would that change my diagnosis?
  5. 5.If a genetic mutation is found, what does that mean for my children or siblings who don't have seizures?
  6. 6.Can you refer me to a genetic counselor to discuss the implications of testing for my family?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Familial Mesial Temporal Lobe Epilepsy: Clinical Spectrum and Genetic Evidence for a Polygenic Architecture.

    Harris RV, Oliver KL, Perucca P, et al.

    Annals of neurology 2023; (94(5)):825-835 doi:10.1002/ana.26765.

    PMID: 37597255
  2. 2

    Familial mesial temporal lobe epilepsy and the borderland of déjà vu.

    Perucca P, Crompton DE, Bellows ST, et al.

    Annals of neurology 2017; (82(2)):166-176 doi:10.1002/ana.24984.

    PMID: 28681459
  3. 3

    DEPDC5-Related Familial Focal Epilepsy With Variable Foci-1: A Report of a Rare Case.

    Itani A, Banjade P, Shrestha U, et al.

    Cureus 2025; (17(5)):e84627 doi:10.7759/cureus.84627.

    PMID: 40546503
  4. 4

    Screening LGI1 in a cohort of 26 lateral temporal lobe epilepsy patients with auditory aura from Turkey detects a novel de novo mutation.

    Kesim YF, Uzun GA, Yucesan E, et al.

    Epilepsy research 2016; (120()):73-8.

    PMID: 26773249
  5. 5

    The clinical phenotype of autosomal dominant lateral temporal lobe epilepsy related to reelin mutations.

    Michelucci R, Pulitano P, Di Bonaventura C, et al.

    Epilepsy & behavior : E&B 2017; (68()):103-107 doi:10.1016/j.yebeh.2016.12.003.

    PMID: 28142128
  6. 6

    DEPDC5 plays a vital role in epilepsy: Genotypic and phenotypic features in cohort and literature.

    Gu C, Wei X, Yan D, et al.

    Epileptic disorders : international epilepsy journal with videotape 2024; (26(3)):341-349 doi:10.1002/epd2.20223.

    PMID: 38752894
  7. 7

    Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy.

    Ricos MG, Hodgson BL, Pippucci T, et al.

    Annals of neurology 2016; (79(1)):120-31 doi:10.1002/ana.24547.

    PMID: 26505888
  8. 8

    Phenotypic and Genotypic Characterization of DEPDC5-Related Familial Focal Epilepsy: Case Series and Literature Review.

    Zhang X, Huang Z, Liu J, et al.

    Frontiers in neurology 2021; (12()):641019 doi:10.3389/fneur.2021.641019.

    PMID: 34239491
  9. 9

    A de novo pathogenic variant in MICAL-1 causes epilepsy with auditory features.

    Bonanni P, Giorda R, Michelucci R, et al.

    Epilepsia open 2024; (9(3)):1083-1087 doi:10.1002/epi4.12937.

    PMID: 38654463
  10. 10

    Incomplete penetrance and variable phenotypes of a novel NPRL2 frameshift variant: from familial focal epilepsy with variable foci 2 to neurodevelopmental disorders.

    Zhu H, Wang Q, Deng W, et al.

    BMC neurology 2025; (25(1)):331 doi:10.1186/s12883-025-04339-6.

    PMID: 40804712
  11. 11

    Temporal lobe epilepsy in patients with nonlesional MRI and normal memory: an SEEG study.

    Suresh S, Sweet J, Fastenau PS, et al.

    Journal of neurosurgery 2015; (123(6)):1368-74 doi:10.3171/2015.1.JNS141811.

    PMID: 26207602
  12. 12

    The Utility of Positron Emission Tomography in Epilepsy.

    Burneo JG, Poon R, Kellett S, Snead OC

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2015; (42(6)):360-71 doi:10.1017/cjn.2015.279.

    PMID: 26437611
  13. 13

    Real-world utility of whole exome sequencing with targeted gene analysis for focal epilepsy.

    Perucca P, Scheffer IE, Harvey AS, et al.

    Epilepsy research 2017; (131()):1-8 doi:10.1016/j.eplepsyres.2017.02.001.

    PMID: 28199897
  14. 14

    Crisis-like Seizure Exacerbations in NPRL3-related Epilepsy: Phenotypic Features and Treatment Outcomes.

    Thormeyer V, Meyer Z, Polster T, et al.

    Neuropediatrics 2026; (57(1)):17-26 doi:10.1055/a-2731-4858.

    PMID: 41260400
  15. 15

    Aberrant RNA splicing caused by variant in DEPDC5 identified in a patient with pharmacoresistant epilepsy.

    Zhou C, Wei X, Xiang Q, et al.

    Neurogenetics 2026; (27(1)).

    PMID: 41838247

This page is for informational purposes only and does not constitute medical advice. Discuss genetic testing, diagnostic results, and family risk with your epilepsy clinician and a genetic counselor.

Get notified when new evidence is published on Familial temporal lobe epilepsy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.